Bionomics Stock Forum

$Bionomics(BNOX.US)$ wow

$Bionomics(BNOX.US)$ Bionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual Meeting! May 28, 29, 30

$Bionomics(BNOX.US)$ Hehehe!

$Bionomics(BNOX.US)$ Watching to see if it holds true! Most times it does. So at this point I believe this is done! JMO

$Bionomics(BNOX.US)$ BNC210 demonstrated a statistically significant improvement in post-traumatic stress disorder (PTSD) symptom severity with a clinically meaningful effect size suggesting a potential advantage over approved medications.
BNC210's emerging safety and tolerability profile continues to support its differentiation over approved, available, and experimental psychoactive treatments.
Bionomics will meet with the U.S. Food & Drug Administration (FDA) to discuss BNC210's...

$Bionomics(BNOX.US)$ Bionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress Disorder
5 MINUTES AGO, 6:00 AM EDT
VIA GLOBENEWSWIRE

$MMTEC Inc(MTC.US)$ this looks good !

$Bionomics(BNOX.US)$ convincing move bought some to play game to test breakabove or not tomorrow

$Bionomics(BNOX.US)$ The Company has no outstanding debt, convertible securities, or warrants.
Continued strengthening BNC210 intellectual property portfolio in the U.S. and abroad.
Future Anticipated Milestones for BNC210 Clinical Program
Bionomics continues to plan the initiation of its first Phase 3 study of BNC210 in patients with SAD.
The Company plans to discuss a potential dose-ranging late-stage study of BNC210 in PTSD with the FDA; an update on the next st...